Borislava Mihaylova

54.0k total citations · 3 hit papers
75 papers, 3.4k citations indexed

About

Borislava Mihaylova is a scholar working on Economics and Econometrics, Surgery and Epidemiology. According to data from OpenAlex, Borislava Mihaylova has authored 75 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 20 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Borislava Mihaylova's work include Health Systems, Economic Evaluations, Quality of Life (29 papers), Lipoproteins and Cardiovascular Health (14 papers) and Chronic Disease Management Strategies (7 papers). Borislava Mihaylova is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (29 papers), Lipoproteins and Cardiovascular Health (14 papers) and Chronic Disease Management Strategies (7 papers). Borislava Mihaylova collaborates with scholars based in United Kingdom, Australia and United States. Borislava Mihaylova's co-authors include Andrew Briggs, Anthony O’Hagan, Simon G. Thompson, Alastair Gray, Jonathan Emberson, Colin Baigent, Rory Collins, Jordan Fulcher, Lisa Blackwell and John Simes and has published in prestigious journals such as The Lancet, Circulation and PLoS ONE.

In The Last Decade

Borislava Mihaylova

70 papers receiving 3.3k citations

Hit Papers

Efficacy and safety of LDL-lowering therapy among men and... 2010 2026 2015 2020 2015 2010 2025 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
    2015 1.0k citations Jordan Fulcher, Jonathan Emberson et al. The Lancet profile →
  2. Review of statistical methods for analysing healthcare resources and costs
    2010 557 citations Borislava Mihaylova, Andrew Briggs et al. Health Economics profile →
  3. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
    2025 16 citations François Mach, Jeanine E. Roeters van Lennep et al. Atherosclerosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Borislava Mihaylova United Kingdom 22 1.2k 967 771 655 443 75 3.4k
Lisandro D. Colantonio United States 34 1.3k 1.1× 889 0.9× 667 0.9× 1.9k 2.8× 435 1.0× 144 4.4k
Colin R. Dormuth Canada 35 763 0.6× 1.2k 1.3× 551 0.7× 547 0.8× 390 0.9× 115 4.3k
Amanda R. Patrick United States 33 566 0.5× 1.0k 1.1× 383 0.5× 909 1.4× 314 0.7× 58 3.9k
Sheldon X. Kong United States 29 637 0.5× 480 0.5× 567 0.7× 356 0.5× 265 0.6× 96 3.2k
Joseph J. Saseen United States 28 842 0.7× 516 0.5× 479 0.6× 693 1.1× 385 0.9× 152 3.1k
Zanfina Ademi Australia 25 810 0.7× 814 0.8× 389 0.5× 558 0.9× 395 0.9× 201 3.1k
Yea‐Huei Kao Yang Taiwan 31 743 0.6× 494 0.5× 528 0.7× 1.1k 1.6× 211 0.5× 107 4.8k
Adrian R. Levy Canada 37 847 0.7× 844 0.9× 186 0.2× 547 0.8× 405 0.9× 141 4.1k
Michael R. Gionfriddo United States 32 652 0.5× 377 0.4× 1.1k 1.4× 372 0.6× 1.1k 2.4× 108 4.0k
Rachel O’Connell Australia 24 983 0.8× 416 0.4× 616 0.8× 529 0.8× 148 0.3× 70 2.7k

Countries citing papers authored by Borislava Mihaylova

Since Specialization
Citations

This map shows the geographic impact of Borislava Mihaylova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Borislava Mihaylova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Borislava Mihaylova more than expected).

Fields of papers citing papers by Borislava Mihaylova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Borislava Mihaylova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Borislava Mihaylova. The network helps show where Borislava Mihaylova may publish in the future.

Co-authorship network of co-authors of Borislava Mihaylova

This figure shows the co-authorship network connecting the top 25 collaborators of Borislava Mihaylova. A scholar is included among the top collaborators of Borislava Mihaylova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Borislava Mihaylova. Borislava Mihaylova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Relton, Clare, Megan Blake, Gemma Bridge, et al.. (2025). Place-based household vouchers for locally supplied fruit and vegetables: the Fresh Street pilot cluster randomised controlled trial. BMC Public Health. 25(1). 29–29.
2.
Mach, François, Jeanine E. Roeters van Lennep, Lâle Tokgözoğlu, et al.. (2025). 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Atherosclerosis. 409. 120479–120479. 16 indexed citations breakdown →
3.
Williams, Claire, Natalie Staplin, Parminder K. Judge, et al.. (2025). Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial. EClinicalMedicine. 85. 103338–103338. 1 indexed citations
4.
Mascio, Livio Di, Thomas Hamborg, Borislava Mihaylova, et al.. (2024). The Adhesive Capsulitis Corticosteroid and Dilation (ACCorD) randomized controlled trial. Bone & Joint Open. 5(3). 162–173. 2 indexed citations
5.
Hart, Ailsa, Fionn Büttner, Thomas Hamborg, et al.. (2024). Fatigue, pain and faecal incontinence in adult inflammatory bowel disease patients and the unmet need: a national cross-sectional survey. BMC Gastroenterology. 24(1). 481–481. 3 indexed citations
6.
Tomini, Florian, et al.. (2023). Strong and graded associations between level of asthma severity and all-cause hospital care use and costs in the UK. BMJ Open Respiratory Research. 10(1). e002003–e002003.
7.
8.
Hart, Ailsa, Laura Miller, Thomas Hamborg, et al.. (2023). DOP59 What is the relationship between fatigue, pain and urgency in people with inflammatory bowel disease? Results of the IBD-BOOST survey in 8486 participants. Journal of Crohn s and Colitis. 17(Supplement_1). i130–i132. 3 indexed citations
9.
10.
Williams, Claire, et al.. (2023). Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial. PharmacoEconomics. 42(3). 261–273. 9 indexed citations
11.
12.
13.
Donovan, Killian, Richard Haynes, David C. Wheeler, et al.. (2018). Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis. Journal of the American Society of Nephrology. 29(7). 2015–2027. 120 indexed citations
14.
Hughes, Dyfrig, et al.. (2016). Health Economics Analysis Plans: Where Are We Now ?. Value in Health. 19(7). A397–A397. 20 indexed citations
15.
Nsungwa‐Sabiiti, Jesca, Borislava Mihaylova, IkeOluwapo O. Ajayi, et al.. (2016). Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs. Clinical Infectious Diseases. 63(suppl 5). S256–S263. 7 indexed citations
16.
Herrington, William G., Jonathan Emberson, Borislava Mihaylova, et al.. (2016). Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. The Lancet Diabetes & Endocrinology. 4(10). 829–839. 203 indexed citations
17.
Mihaylova, Borislava, IkeOluwapo O. Ajayi, Mohamadou Siribié, et al.. (2016). Quantifying and Valuing Community Health Worker Time in Improving Access to Malaria Diagnosis and Treatment. Clinical Infectious Diseases. 63(suppl 5). S298–S305. 7 indexed citations
18.
Alva, María, Alastair Gray, Borislava Mihaylova, & Philip Clarke. (2013). THE EFFECT OF DIABETES COMPLICATIONS ON HEALTH‐RELATED QUALITY OF LIFE: THE IMPORTANCE OF LONGITUDINAL DATA TO ADDRESS PATIENT HETEROGENEITY. Health Economics. 23(4). 487–500. 84 indexed citations
19.
Mihaylova, Borislava, Andrew Briggs, Jane Armitage, et al.. (2005). Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals. The Lancet. 365(9473). 1779–1785. 86 indexed citations
20.
Briggs, Andrew, W. John Armitage, Borislava Mihaylova, et al.. (2003). Economic evaluation of the Heart Protection Study. Circulation. 108. 776–776.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisandro D. Colantonio Breakdown of academic impact, for papers by Colin R. Dormuth Breakdown of academic impact, for papers by Amanda R. Patrick Breakdown of academic impact, for papers by Sheldon X. Kong Breakdown of academic impact, for papers by Joseph J. Saseen Breakdown of academic impact, for papers by Zanfina Ademi Breakdown of academic impact, for papers by Yea‐Huei Kao Yang Breakdown of academic impact, for papers by Adrian R. Levy Breakdown of academic impact, for papers by Michael R. Gionfriddo Breakdown of academic impact, for papers by Rachel O’Connell
Rankless by CCL
2026